Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates Treated With Phototherapy: A Randomized Controlled Trial

NCT07867366 is registered in ClinicalTrials.gov with Muhammad Aamir Latif as lead sponsor.

NCT NCT07867366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07867366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates Treated With Phototherapy: A Randomized Controlled Trial
Lead sponsor
Muhammad Aamir Latif
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2026
Completion date
July 31, 2026
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperbilirubinemia indirect